Eurobio Scientific signe un accord définitif en vue de l'acquisition de la division « Lab Products » de CareDx dédiée à la transplantation
HealthcareAdd-on
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026
Gilead to Acquire Arcellx in $115.00 Cash Tender
Announced
HealthcareCaliforniaMerger
Deal Overview
Gilead Sciences, through wholly owned subsidiary Ravens Sub, has filed an Amendment No. 1 to its Schedule TO tender offer for Arcellx, Inc. The offer seeks to purchase all outstanding Arcellx common stock at $115.00 per share in net cash to the seller.
In addition to the cash price, each share tendered includes one contractual contingent value right (CVR) for a contingent payment of $5.00 per CVR in cash, payable March 31, 2030. The CVR payment is tied to cumulative worldwide sales of Arcellx’s anitocabtagene autoleucel (anito-cel) exceeding $6.0 billion on or prior to December 31, 2029.
The filing references a related Offer to Purchase dated March 6, 2026 and a CVR agreement to be entered into with Computershare entities.
Key Details
- Transaction
- Gilead Sciences acquires Arcellx
- Deal Size
- Over $100M
Filed under
Powered by Tentt
Source healthcare deals in California for your firm
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Seven-figure funding deal secures Swindon site acquisition for medical products firm
HealthcareAdd-on
Quvara Medical→Becton Dickinson
Apr 15, 2026
Indiana hospital signs LOI to join Parkview Health
HealthcareIndianaMerger
Parkview Health→Witham Health Services
Apr 15, 2026
What Surgery Partners’ vascular acquisition means for the industry
HealthcareTENNESSEEAdd-on
Surgery Partners→Preferred Vascular Group
Apr 15, 2026
Sectra completes acquisition of AI firm Oxipit - AuntMinnie
HealthcareAdd-on
Sectra→Oxipit
Apr 15, 2026